These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9702926)

  • 21. Left ventricular hypertrophy in the dialysed patient. What can be done about it?
    Cannella G
    Nephrol Dial Transplant; 1996 Mar; 11(3):418-20. PubMed ID: 8671807
    [No Abstract]   [Full Text] [Related]  

  • 22. Diastolic blood pressure reduction contributes more to the regression of left ventricular hypertrophy: a meta-analysis of randomized controlled trials.
    Zhang K; Chen J; Liu Y; Wang T; Wang L; Wang J; Huang H
    J Hum Hypertens; 2013 Nov; 27(11):698-706. PubMed ID: 23535988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of left ventricular hypertrophy in primary hypertension and therapeutic modification by antihypertensive drugs].
    Schiemann AL; Stimpel M
    Praxis (Bern 1994); 1997 Jul; 86(27-28):1101-6. PubMed ID: 9324718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.
    Muiesan ML; Zulli R; Rizzoni D; Calebich S; Malerba M; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S104-5. PubMed ID: 8158296
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy.
    Kucukler N; Kurt IH; Topaloglu C; Gurbuz S; Yalcin F
    J Cardiovasc Med (Hagerstown); 2012 Mar; 13(3):181-6. PubMed ID: 22306782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of left ventricular hypertrophy in children with antihypertensive therapy.
    Ramaswamy P; Lytrivi ID; Paul C; Golden M; Kupferman JC
    Pediatr Nephrol; 2007 Jan; 22(1):141-3. PubMed ID: 16955278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension and left ventricular hypertrophy: what is the link?
    Arthur A; McNulty CM
    R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
    Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
    Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension and left ventricular hypertrophy: is drug therapy beneficial?
    Eselin JA; Carter BL
    Pharmacotherapy; 1994; 14(1):60-88. PubMed ID: 8159603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular repolarization in hypertension: beyond Bazett.
    Passino C; Emdin M
    Am J Hypertens; 2008 Jan; 21(1):9. PubMed ID: 18091736
    [No Abstract]   [Full Text] [Related]  

  • 34. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy.
    van Zwieten PA
    Cardiovasc Res; 2000 Jan; 45(1):82-91. PubMed ID: 10728317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
    Thürmann PA; Kenedi P; Schmidt A; Harder S; Rietbrock N
    Circulation; 1998 Nov; 98(19):2037-42. PubMed ID: 9808602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is it rational to supplement the concept of "target organ" with a category "dynamic target"?].
    Sidorenko GI
    Kardiologiia; 2009; 49(2):73-5. PubMed ID: 19254222
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of diuretic therapy on hypertensive left ventricular hypertrophy.
    Massie BM
    Eur Heart J; 1992 Dec; 13 Suppl G():53-60. PubMed ID: 1486907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of regression of left ventricular hypertrophy on cardiac function in hypertension.
    Omotoso AB; Dunn FG
    Eur Heart J; 1992 Sep; 13 Suppl D():107-10. PubMed ID: 1396853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
    Mayet J; Ariff B; Wasan B; Chapman N; Shahi M; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 2000 Nov; 36(5):755-9. PubMed ID: 11082139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.